tiprankstipranks
Pharming Group price target raised to EUR 1.85 from EUR 1.75 at RBC Capital
PremiumThe FlyPharming Group price target raised to EUR 1.85 from EUR 1.75 at RBC Capital
2M ago
PHAR Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PHAR Earnings this Week: How Will it Perform?
2M ago
Pharming Group price target lowered to EUR 1.75 from EUR 2.10 at RBC Capital
PremiumThe Fly
Pharming Group price target lowered to EUR 1.75 from EUR 2.10 at RBC Capital
3M ago
Pharming nominates Richard Peters to become chairman
PremiumThe FlyPharming nominates Richard Peters to become chairman
10M ago
Pharming management to meet with Oppenheimer
PremiumThe Fly
Pharming management to meet with Oppenheimer
1y ago
Pharming management to meet with Oppenheimer
PremiumThe Fly
Pharming management to meet with Oppenheimer
1y ago
Pharming announces FDA approval of Joenja
PremiumThe FlyPharming announces FDA approval of Joenja
1y ago
Pharming announces first patient enrolled in leniolisib trial
PremiumThe Fly
Pharming announces first patient enrolled in leniolisib trial
1y ago
Pharming announces CHMP decision to shift leniolisib MAA to standard review
PremiumThe Fly
Pharming announces CHMP decision to shift leniolisib MAA to standard review
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100